Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: A comparison of adenoviral vectors and liposomes

Gene Therapy

Volumn 10, Issue 13, 2003, Pages 1089-1098

  Park, J ^a,b   Ries, J ^a   Gelse, K ^b   Kloss, F ^a   von der Mark, K ^b   Wiltfang, J ^a   Neukam, F W ^a   Schneider, H ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Adenovirus; Bone regeneration; Critical size defect; Gene therapy; Liposome

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN 2; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; LIPOSOME; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; BIOLOGICAL MARKER; BMP2 PROTEIN, RAT; BONE MORPHOGENETIC PROTEIN; SIALOGLYCOPROTEIN; SPP1 PROTEIN, HUMAN; SPP1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE MARROW CELL; BONE MATRIX; BONE RADIOGRAPHY; BONE REGENERATION; BONE TISSUE; CELL ISOLATION; CELL TRANSPLANTATION; CLINICAL STUDY; CONTROLLED STUDY; DNA MODIFICATION; FEMUR; GENE TRANSFER; HEALING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MANDIBLE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RAT; REPORTER GENE; RISK ASSESSMENT; STROMA CELL; VIRAL GENE DELIVERY SYSTEM; ADENOVIRUS; ANIMAL; COMPARATIVE STUDY; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; JAW DISEASE; METHODOLOGY; PATHOLOGY; WISTAR RAT;

ADENOVIRIDAE; ANIMALIA;

ADENOVIRIDAE; ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; GENE THERAPY; GENETIC VECTORS; LIPOSOMES; MANDIBULAR INJURIES; OSTEOCALCIN; OSTEOPONTIN; RATS; RATS, WISTAR; SIALOGLYCOPROTEINS; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0037587239     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301960     Document Type: Article

References (41)

1. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am 2002; 84: 454-464.
2. Wiltfang J et al. Degradation characteristics of alpha and beta tricalcium-phosphate (TCP) in minipigs. J Biomed Mater Res 2002; 63: 115-121.
3. Murphy WL, Mooney DJ. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. J Periodontal Res 1999; 34: 413-419.
4. Perka C et al. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 2000; 21: 1145-1153.
5. Wozney JM et al. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528-1534.
6. Wang EA et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci 1990; 87: 2220-2224.
7. Cook SD, Wolfe MK Salkeld SL, Rueger DC. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 1995; 77: 734-750.
8. Riley EH et al. Bone morphogenetic protein-2: biology and applications [Review]. Clin Orthop 1996; 324: 39-46.
9. Cheng SL et al. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calcif Tissue Int 2001; 68: 87-94.
10. Mehrara B J et al. Adenovirus-mediated gene therapy of osteoblasts in vitro and in vivo. J Bone Miner Res 1999; 14: 1290-1301.
11. Olmsted EA et al. Adenovirus-mediated BMP-2 expression in human bone marrow stromal cells. J Cell Biochem 2001; 82: 11-21.
12. Riew KD et al. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int 1998; 63: 357-360.
13. Lieberman JR et al. Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 1998; 16: 330-339.
14. Lieberman JR et al. The effect of regional gene therapy with bone morphogenetic protein-2 producing bone-marrow cells of repair of segmental femoral defects in rats. J Bone Jt Surg 1999; 81: 905-917.
15. Musgrave DS et al. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 1999; 24: 541-547.
16. Oakes DA, Lieberman JR. Osteoinductive applications of regional gene therapy: ex vivo gene transfer. Clin Orthop 2000; 379S:101-112.
17. Baltzer AW et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 2000; 7: 734-739.
18. Breitbart AS et al. Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann Plast Surg 1999; 42: 488-495.
19. Engstrand T et al. Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation. Hum Gene Ther 2000; 11: 205-211.
20. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997; 389: 239-242.
21. Wang EA, Israel DI, Kelly S, Luxenberg DP. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 1993; 9: 57-71.
22. Gazit D et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J Gene Med 1999; 1: 121-133.
23. Gelse K et al. Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer. Arthritis Rheum 2001; 43: 1156-1164.
24. Gelse K et al. Articular cartilage repair in a rat cartilage defect model by cell-mediated gene therapy using growth factor-producing mesenchymal cells. Arthritis Rheum 2003; 48: 430-441.
25. Kaban LB, Glowacki J. Induced osteogenesis in the repair of experimental bony defects in rats. J Dent Res 1981; 60: 1356.
26. Kaban LB, Glowacki J, Murray JE. Repair of experimental bony defects in rats. Surg Forum 1979; 30: 519.
27. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop 1986; 205: 299-308.
28. Lorente CA, Song BZ, Donoff RB. Healing of bony defects in the irradiated and unirradiated rat mandible. J Oral Maxillofac Surg 1992; 50: 1305-1309.
29. Higuchi T et al. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling. J Periodontol 1999; 70: 1026-1031.
30. Alden TD et al. The use of bone morphogenetic protein gene therapy in craniofacial bone repair. J Craniofac Surg 2000; 11: 24-30.
31. Moutsatsos IK et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 2001; 3: 449-461.
32. Lane JM et al. Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. Clin Orthop 1999; 361: 216.
33. Sellers RS et al. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Bone Jt Surg 2000; 82A: 151.
34. Takushima A, Kitano Y, Harii K. Osteogenic potential of cultured periosteal cells in a distracted bone gap in rabbits. J Surg Res 1998; 78: 68-77.
35. Perka C et al. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 2000; 21: 1145-1153.
36. Hughes SS et al. Shared phenotypic expression of osteoblasts and chondrocytes in fracture callus. J Bone Miner Res 1995; 10: 533-544.
37. Nishimura T, Simmons DJ, Mainous EG. The origin of bone formed by heterotopic periosteal autografts. J Oral Maxillofac Surg 1997; 55: 1265-1268.
38. Harada K, Oida S, Sasaki S. BMP-2 can stimulate the bone marrow stromal cell to differentiate as osteoblast or chondroblast. Bone 1988; 9: 177-183.
39. Harada K et al. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem 2001; 81: 284-294.
40. Rowe NM et al. Rat mandibular distraction osteogenesis: Part I. Histologic and radiographic analysis. Plast Reconstr Surg 1998; 102: 2022-2032.
41. Ikegame M et al. Tensile stress induces bone morphogenetic protein 4 in preosteoblastic and fibroblastic cells, which later differentiate into osteoblasts leading to osteogenesis in the mouse calvariae in organ culture. J Bone Mineral Res 2001; 16: 24-32.